Dr. Zissman has been a member of the Merck vaccine advisory board and is the principal investigator for pediatric clinical research studies for GSK, Merck, Novartis, and Medimmune.
mschneider@frontlinemedcom.com
On Twitter @MaryEllenNY
News
GSK expands two-dimensional barcoding for vaccines
